Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Change in Cash: 2010-2024

Historic Change in Cash for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $154893.0.

  • Cryo Cell International's Change in Cash rose 14699.62% to $127716.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$633591.0, marking a year-over-year decrease of 7236.58%. This contributed to the annual value of $154893.0 for FY2024, which is 11193.42% up from last year.
  • Per Cryo Cell International's latest filing, its Change in Cash stood at $154893.0 for FY2024, which was up 11193.42% from -$1.3 million recorded in FY2023.
  • Cryo Cell International's Change in Cash's 5-year high stood at $3.8 million during FY2020, with a 5-year trough of -$6.6 million in FY2022.
  • Over the past 5 years, Cryo Cell International's median Change in Cash value was -$1.3 million (recorded in 2023), while the average stood at -$1.2 million.
  • In the last 5 years, Cryo Cell International's Change in Cash skyrocketed by 66248.65% in 2020 and then tumbled by 21263.18% in 2022.
  • Cryo Cell International's Change in Cash (Annual) stood at $3.8 million in 2020, then crashed by 154.92% to -$2.1 million in 2021, then tumbled by 212.63% to -$6.6 million in 2022, then skyrocketed by 80.21% to -$1.3 million in 2023, then soared by 111.93% to $154893.0 in 2024.
  • Its Change in Cash stands at $154893.0 for FY2024, versus -$1.3 million for FY2023 and -$6.6 million for FY2022.